Pharmaceutical
| Fri 08 May 2026
Alexandria, May 9 -- Nanjing Chia-Tai Tianqing Pharmaceutical has secured a patent on AKT Inhibitor. Ma Changyou, Tian He, An Jie, Zhao Jianliang, Chen Donghui, Wu Jian, Xu Dan, Zhu Chunxia and Tian Zhoushan developed the invention.
The patent application number is US202017426047 20200122. The patent publication number is US126..